This article provides insufficient context for those unfamiliar with the subject.(March 2021) |
Drofenine is an antimuscarinic antispasmodic drug used for relaxing smooth muscle, thereby treating conditions, such as: dysmenorrhea, and pain in the gastrointestinal tract, biliary passages, and urogenital tract. Drofenine is assumed to work by increasing the levels of the protein TRPV3.[1][2][3]
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.114.553 |
Chemical and physical data | |
Formula | C20H31NO2 |
Molar mass | 317.473 g·mol−1 |
3D model (JSmol) | |
| |
|
References
edit- ^ Kunysz EL, Michel AD, Whiting RL (March 1988). "Functional and direct binding studies using subtype selective muscarinic receptor antagonists". British Journal of Pharmacology. 93 (3): 491–500. doi:10.1111/j.1476-5381.1988.tb10303.x. PMC 1853838. PMID 2897216.
- ^ Bodur E, Cokuğraş AN, Tezcan EF (February 2001). "Inhibition effects of benactyzine and drofenine on human serum butyrylcholinesterase". Archives of Biochemistry and Biophysics. 386 (1): 25–9. doi:10.1006/abbi.2000.2188. PMID 11360997.
- ^ Deering-Rice CE, Mitchell VK, Romero EG, Abdel Aziz MH, Ryskamp DA, Križaj D, et al. (October 2014). "Drofenine: A 2-APB Analogue with Greater Selectivity for Human TRPV3". Pharmacology Research & Perspectives. 2 (5): e00062. doi:10.1002/prp2.62. PMC 4115637. PMID 25089200.